Journal for ImmunoTherapy of Cancer-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=588492, encodeId=4865588492fb, content=没有，显示的是awaiting reviewer scroes.oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, beContent=oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d665160122, createdName=146b5070m17暂无昵称, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996027, encodeId=861499602ea9, content=这个杂志的审稿流程到底是什么样子呀？有点蒙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Sun Jul 04 10:57:32 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997775, encodeId=d6f099e775b4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫;纳米 经验分享：03.17 投稿，很快进入审稿阶段； 04.06 大修，期限2个月； 05.05 大修返回，很快进入审稿阶段； 06.02 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Fri Jul 09 08:38:11 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223473, encodeId=4d9112234e326, content=审稿速度:1.0 经验分享：5月1 投稿 5月17 awaiting reviewer scores 5月26 告知主编将发decision letter 5月27 早上7:30，小修香港疫情好转，现在加班加点改稿子中，要补的一个实验猜中，提前在等待中做完了，希望好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794e8145109, createdName=ms2000001308610491, createdTime=Mon May 30 23:16:38 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190771, encodeId=73611190e7198, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：经验分享：2021.7.3投稿 2021.9.14大修 2022.1.9修回 2022.1.28接收 杂志的状态有点迷惑人，建议投搞之后不要刷状态，不然心态会崩，安心做自己的工作，等待邮件通知即可，大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a65e3120259, createdName=hujianjun92, createdTime=Mon Feb 07 17:08:23 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206787, encodeId=066a1206e87fe, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：RNA生物学;肿瘤免疫 经验分享：2021年9月9日投稿，11月26日大修（给了两个月修回，四个审稿人，审稿意见太多了，不过很专业，按照要求补实验和修改后明显感觉文章更完整和深入了），2022年1月25日趁着最后期限修回，3月10日小修，3月17日修回，3月28日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 29 07:46:13 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967207, encodeId=f1ce96e207ad, content=这个杂志现在是怎么了一个月一动不动杂志主页提示受疫情影响编辑部有困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=ms9000001861825321, createdTime=Thu May 20 13:10:08 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137975, encodeId=8ce6213e975bb, content=修回后awaiting recommendation已经5天了，一直没变状态，有点慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d842084788, createdName=1321f2f792m, createdTime=Sat May 20 07:30:56 CST 2023, time=2023-05-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1215204, encodeId=52b912152047e, content=十天从awaiting reviewer scores 变成了awaiting recommendation是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=605a2438688, createdName=123cddb2m15暂无昵称, createdTime=Thu Apr 28 01:48:53 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203650, encodeId=74872203650d2, content=偏重的研究方向：免疫治疗;肿瘤免疫 经验分享：记录一下,欢迎讨论:Awaiting Section Editor Handling第五天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/8f4d9a6f23b8461d87167a9eb33dbade/bcf9695792c341e78d98af66955952d2.jpg, createdBy=cf0c2504738, createdName=普外小王, createdTime=Thu May 09 12:38:54 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省)]

2020-04-09 146b5070m17暂无昵称

没有，显示的是awaiting reviewer scroes.oncosurgeon_J 2020-04-09 00:00:00 发表:
请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？

oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？

219 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=588492, encodeId=4865588492fb, content=没有，显示的是awaiting reviewer scroes.oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, beContent=oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d665160122, createdName=146b5070m17暂无昵称, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996027, encodeId=861499602ea9, content=这个杂志的审稿流程到底是什么样子呀？有点蒙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Sun Jul 04 10:57:32 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997775, encodeId=d6f099e775b4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫;纳米 经验分享：03.17 投稿，很快进入审稿阶段； 04.06 大修，期限2个月； 05.05 大修返回，很快进入审稿阶段； 06.02 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Fri Jul 09 08:38:11 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223473, encodeId=4d9112234e326, content=审稿速度:1.0 经验分享：5月1 投稿 5月17 awaiting reviewer scores 5月26 告知主编将发decision letter 5月27 早上7:30，小修香港疫情好转，现在加班加点改稿子中，要补的一个实验猜中，提前在等待中做完了，希望好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794e8145109, createdName=ms2000001308610491, createdTime=Mon May 30 23:16:38 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190771, encodeId=73611190e7198, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：经验分享：2021.7.3投稿 2021.9.14大修 2022.1.9修回 2022.1.28接收 杂志的状态有点迷惑人，建议投搞之后不要刷状态，不然心态会崩，安心做自己的工作，等待邮件通知即可，大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a65e3120259, createdName=hujianjun92, createdTime=Mon Feb 07 17:08:23 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206787, encodeId=066a1206e87fe, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：RNA生物学;肿瘤免疫 经验分享：2021年9月9日投稿，11月26日大修（给了两个月修回，四个审稿人，审稿意见太多了，不过很专业，按照要求补实验和修改后明显感觉文章更完整和深入了），2022年1月25日趁着最后期限修回，3月10日小修，3月17日修回，3月28日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 29 07:46:13 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967207, encodeId=f1ce96e207ad, content=这个杂志现在是怎么了一个月一动不动杂志主页提示受疫情影响编辑部有困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=ms9000001861825321, createdTime=Thu May 20 13:10:08 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137975, encodeId=8ce6213e975bb, content=修回后awaiting recommendation已经5天了，一直没变状态，有点慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d842084788, createdName=1321f2f792m, createdTime=Sat May 20 07:30:56 CST 2023, time=2023-05-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1215204, encodeId=52b912152047e, content=十天从awaiting reviewer scores 变成了awaiting recommendation是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=605a2438688, createdName=123cddb2m15暂无昵称, createdTime=Thu Apr 28 01:48:53 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203650, encodeId=74872203650d2, content=偏重的研究方向：免疫治疗;肿瘤免疫 经验分享：记录一下,欢迎讨论:Awaiting Section Editor Handling第五天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/8f4d9a6f23b8461d87167a9eb33dbade/bcf9695792c341e78d98af66955952d2.jpg, createdBy=cf0c2504738, createdName=普外小王, createdTime=Thu May 09 12:38:54 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省)]

2021-07-04 喵了个咪5371

这个杂志的审稿流程到底是什么样子呀？有点蒙

62 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=588492, encodeId=4865588492fb, content=没有，显示的是awaiting reviewer scroes.oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, beContent=oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d665160122, createdName=146b5070m17暂无昵称, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996027, encodeId=861499602ea9, content=这个杂志的审稿流程到底是什么样子呀？有点蒙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Sun Jul 04 10:57:32 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997775, encodeId=d6f099e775b4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫;纳米 经验分享：03.17 投稿，很快进入审稿阶段； 04.06 大修，期限2个月； 05.05 大修返回，很快进入审稿阶段； 06.02 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Fri Jul 09 08:38:11 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223473, encodeId=4d9112234e326, content=审稿速度:1.0 经验分享：5月1 投稿 5月17 awaiting reviewer scores 5月26 告知主编将发decision letter 5月27 早上7:30，小修香港疫情好转，现在加班加点改稿子中，要补的一个实验猜中，提前在等待中做完了，希望好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794e8145109, createdName=ms2000001308610491, createdTime=Mon May 30 23:16:38 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190771, encodeId=73611190e7198, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：经验分享：2021.7.3投稿 2021.9.14大修 2022.1.9修回 2022.1.28接收 杂志的状态有点迷惑人，建议投搞之后不要刷状态，不然心态会崩，安心做自己的工作，等待邮件通知即可，大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a65e3120259, createdName=hujianjun92, createdTime=Mon Feb 07 17:08:23 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206787, encodeId=066a1206e87fe, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：RNA生物学;肿瘤免疫 经验分享：2021年9月9日投稿，11月26日大修（给了两个月修回，四个审稿人，审稿意见太多了，不过很专业，按照要求补实验和修改后明显感觉文章更完整和深入了），2022年1月25日趁着最后期限修回，3月10日小修，3月17日修回，3月28日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 29 07:46:13 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967207, encodeId=f1ce96e207ad, content=这个杂志现在是怎么了一个月一动不动杂志主页提示受疫情影响编辑部有困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=ms9000001861825321, createdTime=Thu May 20 13:10:08 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137975, encodeId=8ce6213e975bb, content=修回后awaiting recommendation已经5天了，一直没变状态，有点慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d842084788, createdName=1321f2f792m, createdTime=Sat May 20 07:30:56 CST 2023, time=2023-05-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1215204, encodeId=52b912152047e, content=十天从awaiting reviewer scores 变成了awaiting recommendation是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=605a2438688, createdName=123cddb2m15暂无昵称, createdTime=Thu Apr 28 01:48:53 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203650, encodeId=74872203650d2, content=偏重的研究方向：免疫治疗;肿瘤免疫 经验分享：记录一下,欢迎讨论:Awaiting Section Editor Handling第五天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/8f4d9a6f23b8461d87167a9eb33dbade/bcf9695792c341e78d98af66955952d2.jpg, createdBy=cf0c2504738, createdName=普外小王, createdTime=Thu May 09 12:38:54 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省)]

2021-07-09 yelinghao215

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤免疫;纳米
经验分享：03.17 投稿，很快进入审稿阶段；
04.06 大修，期限2个月；
05.05 大修返回，很快进入审稿阶段；
06.02 接收。

118 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=588492, encodeId=4865588492fb, content=没有，显示的是awaiting reviewer scroes.oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, beContent=oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d665160122, createdName=146b5070m17暂无昵称, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996027, encodeId=861499602ea9, content=这个杂志的审稿流程到底是什么样子呀？有点蒙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Sun Jul 04 10:57:32 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997775, encodeId=d6f099e775b4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫;纳米 经验分享：03.17 投稿，很快进入审稿阶段； 04.06 大修，期限2个月； 05.05 大修返回，很快进入审稿阶段； 06.02 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Fri Jul 09 08:38:11 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223473, encodeId=4d9112234e326, content=审稿速度:1.0 经验分享：5月1 投稿 5月17 awaiting reviewer scores 5月26 告知主编将发decision letter 5月27 早上7:30，小修香港疫情好转，现在加班加点改稿子中，要补的一个实验猜中，提前在等待中做完了，希望好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794e8145109, createdName=ms2000001308610491, createdTime=Mon May 30 23:16:38 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190771, encodeId=73611190e7198, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：经验分享：2021.7.3投稿 2021.9.14大修 2022.1.9修回 2022.1.28接收 杂志的状态有点迷惑人，建议投搞之后不要刷状态，不然心态会崩，安心做自己的工作，等待邮件通知即可，大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a65e3120259, createdName=hujianjun92, createdTime=Mon Feb 07 17:08:23 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206787, encodeId=066a1206e87fe, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：RNA生物学;肿瘤免疫 经验分享：2021年9月9日投稿，11月26日大修（给了两个月修回，四个审稿人，审稿意见太多了，不过很专业，按照要求补实验和修改后明显感觉文章更完整和深入了），2022年1月25日趁着最后期限修回，3月10日小修，3月17日修回，3月28日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 29 07:46:13 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967207, encodeId=f1ce96e207ad, content=这个杂志现在是怎么了一个月一动不动杂志主页提示受疫情影响编辑部有困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=ms9000001861825321, createdTime=Thu May 20 13:10:08 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137975, encodeId=8ce6213e975bb, content=修回后awaiting recommendation已经5天了，一直没变状态，有点慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d842084788, createdName=1321f2f792m, createdTime=Sat May 20 07:30:56 CST 2023, time=2023-05-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1215204, encodeId=52b912152047e, content=十天从awaiting reviewer scores 变成了awaiting recommendation是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=605a2438688, createdName=123cddb2m15暂无昵称, createdTime=Thu Apr 28 01:48:53 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203650, encodeId=74872203650d2, content=偏重的研究方向：免疫治疗;肿瘤免疫 经验分享：记录一下,欢迎讨论:Awaiting Section Editor Handling第五天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/8f4d9a6f23b8461d87167a9eb33dbade/bcf9695792c341e78d98af66955952d2.jpg, createdBy=cf0c2504738, createdName=普外小王, createdTime=Thu May 09 12:38:54 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省)]

2022-05-30 ms2000001308610491

审稿速度:1.0
经验分享：5月1 投稿 5月17 awaiting reviewer scores 5月26 告知主编将发decision letter 5月27 早上7:30，小修香港疫情好转，现在加班加点改稿子中，要补的一个实验猜中，提前在等待中做完了，希望好运🍀

105 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=588492, encodeId=4865588492fb, content=没有，显示的是awaiting reviewer scroes.oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, beContent=oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d665160122, createdName=146b5070m17暂无昵称, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996027, encodeId=861499602ea9, content=这个杂志的审稿流程到底是什么样子呀？有点蒙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Sun Jul 04 10:57:32 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997775, encodeId=d6f099e775b4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫;纳米 经验分享：03.17 投稿，很快进入审稿阶段； 04.06 大修，期限2个月； 05.05 大修返回，很快进入审稿阶段； 06.02 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Fri Jul 09 08:38:11 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223473, encodeId=4d9112234e326, content=审稿速度:1.0 经验分享：5月1 投稿 5月17 awaiting reviewer scores 5月26 告知主编将发decision letter 5月27 早上7:30，小修香港疫情好转，现在加班加点改稿子中，要补的一个实验猜中，提前在等待中做完了，希望好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794e8145109, createdName=ms2000001308610491, createdTime=Mon May 30 23:16:38 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190771, encodeId=73611190e7198, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：经验分享：2021.7.3投稿 2021.9.14大修 2022.1.9修回 2022.1.28接收 杂志的状态有点迷惑人，建议投搞之后不要刷状态，不然心态会崩，安心做自己的工作，等待邮件通知即可，大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a65e3120259, createdName=hujianjun92, createdTime=Mon Feb 07 17:08:23 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206787, encodeId=066a1206e87fe, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：RNA生物学;肿瘤免疫 经验分享：2021年9月9日投稿，11月26日大修（给了两个月修回，四个审稿人，审稿意见太多了，不过很专业，按照要求补实验和修改后明显感觉文章更完整和深入了），2022年1月25日趁着最后期限修回，3月10日小修，3月17日修回，3月28日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 29 07:46:13 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967207, encodeId=f1ce96e207ad, content=这个杂志现在是怎么了一个月一动不动杂志主页提示受疫情影响编辑部有困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=ms9000001861825321, createdTime=Thu May 20 13:10:08 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137975, encodeId=8ce6213e975bb, content=修回后awaiting recommendation已经5天了，一直没变状态，有点慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d842084788, createdName=1321f2f792m, createdTime=Sat May 20 07:30:56 CST 2023, time=2023-05-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1215204, encodeId=52b912152047e, content=十天从awaiting reviewer scores 变成了awaiting recommendation是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=605a2438688, createdName=123cddb2m15暂无昵称, createdTime=Thu Apr 28 01:48:53 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203650, encodeId=74872203650d2, content=偏重的研究方向：免疫治疗;肿瘤免疫 经验分享：记录一下,欢迎讨论:Awaiting Section Editor Handling第五天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/8f4d9a6f23b8461d87167a9eb33dbade/bcf9695792c341e78d98af66955952d2.jpg, createdBy=cf0c2504738, createdName=普外小王, createdTime=Thu May 09 12:38:54 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省)]

2022-02-07 hujianjun92

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤免疫
经验分享：经验分享：2021.7.3投稿
2021.9.14大修
2022.1.9修回
2022.1.28接收
杂志的状态有点迷惑人，建议投搞之后不要刷状态，不然心态会崩，安心做自己的工作，等待邮件通知即可，大家加油！

161 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=588492, encodeId=4865588492fb, content=没有，显示的是awaiting reviewer scroes.oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, beContent=oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d665160122, createdName=146b5070m17暂无昵称, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996027, encodeId=861499602ea9, content=这个杂志的审稿流程到底是什么样子呀？有点蒙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Sun Jul 04 10:57:32 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997775, encodeId=d6f099e775b4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫;纳米 经验分享：03.17 投稿，很快进入审稿阶段； 04.06 大修，期限2个月； 05.05 大修返回，很快进入审稿阶段； 06.02 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Fri Jul 09 08:38:11 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223473, encodeId=4d9112234e326, content=审稿速度:1.0 经验分享：5月1 投稿 5月17 awaiting reviewer scores 5月26 告知主编将发decision letter 5月27 早上7:30，小修香港疫情好转，现在加班加点改稿子中，要补的一个实验猜中，提前在等待中做完了，希望好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794e8145109, createdName=ms2000001308610491, createdTime=Mon May 30 23:16:38 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190771, encodeId=73611190e7198, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：经验分享：2021.7.3投稿 2021.9.14大修 2022.1.9修回 2022.1.28接收 杂志的状态有点迷惑人，建议投搞之后不要刷状态，不然心态会崩，安心做自己的工作，等待邮件通知即可，大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a65e3120259, createdName=hujianjun92, createdTime=Mon Feb 07 17:08:23 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206787, encodeId=066a1206e87fe, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：RNA生物学;肿瘤免疫 经验分享：2021年9月9日投稿，11月26日大修（给了两个月修回，四个审稿人，审稿意见太多了，不过很专业，按照要求补实验和修改后明显感觉文章更完整和深入了），2022年1月25日趁着最后期限修回，3月10日小修，3月17日修回，3月28日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 29 07:46:13 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967207, encodeId=f1ce96e207ad, content=这个杂志现在是怎么了一个月一动不动杂志主页提示受疫情影响编辑部有困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=ms9000001861825321, createdTime=Thu May 20 13:10:08 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137975, encodeId=8ce6213e975bb, content=修回后awaiting recommendation已经5天了，一直没变状态，有点慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d842084788, createdName=1321f2f792m, createdTime=Sat May 20 07:30:56 CST 2023, time=2023-05-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1215204, encodeId=52b912152047e, content=十天从awaiting reviewer scores 变成了awaiting recommendation是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=605a2438688, createdName=123cddb2m15暂无昵称, createdTime=Thu Apr 28 01:48:53 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203650, encodeId=74872203650d2, content=偏重的研究方向：免疫治疗;肿瘤免疫 经验分享：记录一下,欢迎讨论:Awaiting Section Editor Handling第五天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/8f4d9a6f23b8461d87167a9eb33dbade/bcf9695792c341e78d98af66955952d2.jpg, createdBy=cf0c2504738, createdName=普外小王, createdTime=Thu May 09 12:38:54 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省)]

2022-03-29 princesun083

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：RNA生物学;肿瘤免疫
经验分享：2021年9月9日投稿，11月26日大修（给了两个月修回，四个审稿人，审稿意见太多了，不过很专业，按照要求补实验和修改后明显感觉文章更完整和深入了），2022年1月25日趁着最后期限修回，3月10日小修，3月17日修回，3月28日接收。

294 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=588492, encodeId=4865588492fb, content=没有，显示的是awaiting reviewer scroes.oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, beContent=oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d665160122, createdName=146b5070m17暂无昵称, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996027, encodeId=861499602ea9, content=这个杂志的审稿流程到底是什么样子呀？有点蒙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Sun Jul 04 10:57:32 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997775, encodeId=d6f099e775b4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫;纳米 经验分享：03.17 投稿，很快进入审稿阶段； 04.06 大修，期限2个月； 05.05 大修返回，很快进入审稿阶段； 06.02 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Fri Jul 09 08:38:11 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223473, encodeId=4d9112234e326, content=审稿速度:1.0 经验分享：5月1 投稿 5月17 awaiting reviewer scores 5月26 告知主编将发decision letter 5月27 早上7:30，小修香港疫情好转，现在加班加点改稿子中，要补的一个实验猜中，提前在等待中做完了，希望好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794e8145109, createdName=ms2000001308610491, createdTime=Mon May 30 23:16:38 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190771, encodeId=73611190e7198, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：经验分享：2021.7.3投稿 2021.9.14大修 2022.1.9修回 2022.1.28接收 杂志的状态有点迷惑人，建议投搞之后不要刷状态，不然心态会崩，安心做自己的工作，等待邮件通知即可，大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a65e3120259, createdName=hujianjun92, createdTime=Mon Feb 07 17:08:23 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206787, encodeId=066a1206e87fe, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：RNA生物学;肿瘤免疫 经验分享：2021年9月9日投稿，11月26日大修（给了两个月修回，四个审稿人，审稿意见太多了，不过很专业，按照要求补实验和修改后明显感觉文章更完整和深入了），2022年1月25日趁着最后期限修回，3月10日小修，3月17日修回，3月28日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 29 07:46:13 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967207, encodeId=f1ce96e207ad, content=这个杂志现在是怎么了一个月一动不动杂志主页提示受疫情影响编辑部有困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=ms9000001861825321, createdTime=Thu May 20 13:10:08 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137975, encodeId=8ce6213e975bb, content=修回后awaiting recommendation已经5天了，一直没变状态，有点慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d842084788, createdName=1321f2f792m, createdTime=Sat May 20 07:30:56 CST 2023, time=2023-05-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1215204, encodeId=52b912152047e, content=十天从awaiting reviewer scores 变成了awaiting recommendation是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=605a2438688, createdName=123cddb2m15暂无昵称, createdTime=Thu Apr 28 01:48:53 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203650, encodeId=74872203650d2, content=偏重的研究方向：免疫治疗;肿瘤免疫 经验分享：记录一下,欢迎讨论:Awaiting Section Editor Handling第五天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/8f4d9a6f23b8461d87167a9eb33dbade/bcf9695792c341e78d98af66955952d2.jpg, createdBy=cf0c2504738, createdName=普外小王, createdTime=Thu May 09 12:38:54 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省)]

2021-05-20 ms9000001861825321

这个杂志现在是怎么了一个月一动不动杂志主页提示受疫情影响编辑部有困难

58 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=588492, encodeId=4865588492fb, content=没有，显示的是awaiting reviewer scroes.oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, beContent=oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d665160122, createdName=146b5070m17暂无昵称, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996027, encodeId=861499602ea9, content=这个杂志的审稿流程到底是什么样子呀？有点蒙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Sun Jul 04 10:57:32 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997775, encodeId=d6f099e775b4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫;纳米 经验分享：03.17 投稿，很快进入审稿阶段； 04.06 大修，期限2个月； 05.05 大修返回，很快进入审稿阶段； 06.02 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Fri Jul 09 08:38:11 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223473, encodeId=4d9112234e326, content=审稿速度:1.0 经验分享：5月1 投稿 5月17 awaiting reviewer scores 5月26 告知主编将发decision letter 5月27 早上7:30，小修香港疫情好转，现在加班加点改稿子中，要补的一个实验猜中，提前在等待中做完了，希望好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794e8145109, createdName=ms2000001308610491, createdTime=Mon May 30 23:16:38 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190771, encodeId=73611190e7198, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：经验分享：2021.7.3投稿 2021.9.14大修 2022.1.9修回 2022.1.28接收 杂志的状态有点迷惑人，建议投搞之后不要刷状态，不然心态会崩，安心做自己的工作，等待邮件通知即可，大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a65e3120259, createdName=hujianjun92, createdTime=Mon Feb 07 17:08:23 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206787, encodeId=066a1206e87fe, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：RNA生物学;肿瘤免疫 经验分享：2021年9月9日投稿，11月26日大修（给了两个月修回，四个审稿人，审稿意见太多了，不过很专业，按照要求补实验和修改后明显感觉文章更完整和深入了），2022年1月25日趁着最后期限修回，3月10日小修，3月17日修回，3月28日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 29 07:46:13 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967207, encodeId=f1ce96e207ad, content=这个杂志现在是怎么了一个月一动不动杂志主页提示受疫情影响编辑部有困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=ms9000001861825321, createdTime=Thu May 20 13:10:08 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137975, encodeId=8ce6213e975bb, content=修回后awaiting recommendation已经5天了，一直没变状态，有点慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d842084788, createdName=1321f2f792m, createdTime=Sat May 20 07:30:56 CST 2023, time=2023-05-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1215204, encodeId=52b912152047e, content=十天从awaiting reviewer scores 变成了awaiting recommendation是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=605a2438688, createdName=123cddb2m15暂无昵称, createdTime=Thu Apr 28 01:48:53 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203650, encodeId=74872203650d2, content=偏重的研究方向：免疫治疗;肿瘤免疫 经验分享：记录一下,欢迎讨论:Awaiting Section Editor Handling第五天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/8f4d9a6f23b8461d87167a9eb33dbade/bcf9695792c341e78d98af66955952d2.jpg, createdBy=cf0c2504738, createdName=普外小王, createdTime=Thu May 09 12:38:54 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省)]

2023-05-20 1321f2f792m 来自陕西省

修回后awaiting recommendation已经5天了，一直没变状态，有点慌。

60 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=588492, encodeId=4865588492fb, content=没有，显示的是awaiting reviewer scroes.oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, beContent=oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d665160122, createdName=146b5070m17暂无昵称, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996027, encodeId=861499602ea9, content=这个杂志的审稿流程到底是什么样子呀？有点蒙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Sun Jul 04 10:57:32 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997775, encodeId=d6f099e775b4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫;纳米 经验分享：03.17 投稿，很快进入审稿阶段； 04.06 大修，期限2个月； 05.05 大修返回，很快进入审稿阶段； 06.02 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Fri Jul 09 08:38:11 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223473, encodeId=4d9112234e326, content=审稿速度:1.0 经验分享：5月1 投稿 5月17 awaiting reviewer scores 5月26 告知主编将发decision letter 5月27 早上7:30，小修香港疫情好转，现在加班加点改稿子中，要补的一个实验猜中，提前在等待中做完了，希望好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794e8145109, createdName=ms2000001308610491, createdTime=Mon May 30 23:16:38 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190771, encodeId=73611190e7198, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：经验分享：2021.7.3投稿 2021.9.14大修 2022.1.9修回 2022.1.28接收 杂志的状态有点迷惑人，建议投搞之后不要刷状态，不然心态会崩，安心做自己的工作，等待邮件通知即可，大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a65e3120259, createdName=hujianjun92, createdTime=Mon Feb 07 17:08:23 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206787, encodeId=066a1206e87fe, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：RNA生物学;肿瘤免疫 经验分享：2021年9月9日投稿，11月26日大修（给了两个月修回，四个审稿人，审稿意见太多了，不过很专业，按照要求补实验和修改后明显感觉文章更完整和深入了），2022年1月25日趁着最后期限修回，3月10日小修，3月17日修回，3月28日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 29 07:46:13 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967207, encodeId=f1ce96e207ad, content=这个杂志现在是怎么了一个月一动不动杂志主页提示受疫情影响编辑部有困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=ms9000001861825321, createdTime=Thu May 20 13:10:08 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137975, encodeId=8ce6213e975bb, content=修回后awaiting recommendation已经5天了，一直没变状态，有点慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d842084788, createdName=1321f2f792m, createdTime=Sat May 20 07:30:56 CST 2023, time=2023-05-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1215204, encodeId=52b912152047e, content=十天从awaiting reviewer scores 变成了awaiting recommendation是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=605a2438688, createdName=123cddb2m15暂无昵称, createdTime=Thu Apr 28 01:48:53 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203650, encodeId=74872203650d2, content=偏重的研究方向：免疫治疗;肿瘤免疫 经验分享：记录一下,欢迎讨论:Awaiting Section Editor Handling第五天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/8f4d9a6f23b8461d87167a9eb33dbade/bcf9695792c341e78d98af66955952d2.jpg, createdBy=cf0c2504738, createdName=普外小王, createdTime=Thu May 09 12:38:54 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省)]

2022-04-28 123cddb2m15暂无昵称

十天从awaiting reviewer scores 变成了awaiting recommendation是什么情况啊

107 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=588492, encodeId=4865588492fb, content=没有，显示的是awaiting reviewer scroes.oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, beContent=oncosurgeon_J 2020-04-09 00:00:00 发表: 请问这个杂志有无“under review”状态？一月前投稿，awaiting for reviewer section- awaiting for reviewer assigned现在又变成awaiting for reviewer section这是外审还是还在编辑手里？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d665160122, createdName=146b5070m17暂无昵称, createdTime=Thu Apr 09 00:00:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996027, encodeId=861499602ea9, content=这个杂志的审稿流程到底是什么样子呀？有点蒙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Sun Jul 04 10:57:32 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997775, encodeId=d6f099e775b4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫;纳米 经验分享：03.17 投稿，很快进入审稿阶段； 04.06 大修，期限2个月； 05.05 大修返回，很快进入审稿阶段； 06.02 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Fri Jul 09 08:38:11 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223473, encodeId=4d9112234e326, content=审稿速度:1.0 经验分享：5月1 投稿 5月17 awaiting reviewer scores 5月26 告知主编将发decision letter 5月27 早上7:30，小修香港疫情好转，现在加班加点改稿子中，要补的一个实验猜中，提前在等待中做完了，希望好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=794e8145109, createdName=ms2000001308610491, createdTime=Mon May 30 23:16:38 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190771, encodeId=73611190e7198, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：经验分享：2021.7.3投稿 2021.9.14大修 2022.1.9修回 2022.1.28接收 杂志的状态有点迷惑人，建议投搞之后不要刷状态，不然心态会崩，安心做自己的工作，等待邮件通知即可，大家加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a65e3120259, createdName=hujianjun92, createdTime=Mon Feb 07 17:08:23 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206787, encodeId=066a1206e87fe, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：RNA生物学;肿瘤免疫 经验分享：2021年9月9日投稿，11月26日大修（给了两个月修回，四个审稿人，审稿意见太多了，不过很专业，按照要求补实验和修改后明显感觉文章更完整和深入了），2022年1月25日趁着最后期限修回，3月10日小修，3月17日修回，3月28日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Tue Mar 29 07:46:13 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967207, encodeId=f1ce96e207ad, content=这个杂志现在是怎么了一个月一动不动杂志主页提示受疫情影响编辑部有困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=ms9000001861825321, createdTime=Thu May 20 13:10:08 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137975, encodeId=8ce6213e975bb, content=修回后awaiting recommendation已经5天了，一直没变状态，有点慌。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d842084788, createdName=1321f2f792m, createdTime=Sat May 20 07:30:56 CST 2023, time=2023-05-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1215204, encodeId=52b912152047e, content=十天从awaiting reviewer scores 变成了awaiting recommendation是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=605a2438688, createdName=123cddb2m15暂无昵称, createdTime=Thu Apr 28 01:48:53 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203650, encodeId=74872203650d2, content=偏重的研究方向：免疫治疗;肿瘤免疫 经验分享：记录一下,欢迎讨论:Awaiting Section Editor Handling第五天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/8f4d9a6f23b8461d87167a9eb33dbade/bcf9695792c341e78d98af66955952d2.jpg, createdBy=cf0c2504738, createdName=普外小王, createdTime=Thu May 09 12:38:54 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省)]

2024-05-09 普外小王来自江苏省

偏重的研究方向：免疫治疗;肿瘤免疫
经验分享：记录一下,欢迎讨论:Awaiting Section Editor Handling第五天。

2 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务